Aurobindo Pharma Ltd rises for third straight session

Aurobindo Pharma Ltd is quoting at Rs 1197.8, up 1.65% on the day as on 12:49 IST on the NSE. The stock is up 5.66% in last one year as compared to a 9.94% jump in NIFTY and a 26.31% jump in the Nifty Pharma index.

Aurobindo Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1197.8, up 1.65% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.64% on the day, quoting at 23350.8. The Sensex is at 77182.56, up 0.74%. Aurobindo Pharma Ltd has slipped around 4.4% in last one month.

Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has slipped around 1.96% in last one month and is currently quoting at 22061.7, up 0.31% on the day. The volume in the stock stood at 4.31 lakh shares today, compared to the daily average of 11.52 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 1197.6, up 1.54% on the day. Aurobindo Pharma Ltd is up 5.66% in last one year as compared to a 9.94% jump in NIFTY and a 26.31% jump in the Nifty Pharma index.

  • Related Posts

    Meiji Seika to push new vaccine with SII in India

    TOKYO: Meiji Seika Pharma-owned Medreich Pharma is eyeing inorganic growth and more generics supply from India, while the parent has tied up with Serum Institute of India (SII) to launch…

    DGFT automates EO extension process to ease compliance for pharma exporters

    Mumbai: The Directorate General of Foreign Trade (DGFT) has introduced an automated facility for granting Export Obligation (EO) extensions in Advance Authorisation and Export Promotion Capital Goods (EPCG) Authorisation cases…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Meiji Seika to push new vaccine with SII in India

    Meiji Seika to push new vaccine with SII in India

    DGFT automates EO extension process to ease compliance for pharma exporters

    DGFT automates EO extension process to ease compliance for pharma exporters

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

    Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

    Three newborns die in fire at government hospital in Amravati, Maharashtra

    Three newborns die in fire at government hospital in Amravati, Maharashtra

    Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner

    Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner

    Centre bans fixed-dose combination for Common Cold in children below four

    Centre bans fixed-dose combination for Common Cold in children below four